David S. Bardenstein

Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma

Michael D. Onken, Lori A. Worley, Devron H. Char et al. · Ophthalmology · 2012 · 496 citations · Full text

Ocular Disease, Oncology, Uveal Melanoma +10

Cell Uptake and <i>in Vitro</i> Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery

Urs O. Häfeli, Judy S. Riffle, Linda Harris-Shekhawat et al. · Molecular Pharmaceutics · 2009 · 272 citations

Nanoparticles, Engineering, Polymer-based Magnet +16

A Multicenter Study to Map Genes for Fuchs Endothelial Corneal Dystrophy: Baseline Characteristics and Heritability

M. Louttit, Laura J. Kopplin, Robert P. Igo et al. · Cornea · 2011 · 119 citations · Full text

Linezolid-associated toxic optic neuropathy

Janet C. Rucker, S. R. Hamilton, David S. Bardenstein et al. · Neurology · 2006 · 112 citations

Peripheral Neuropathy, Ocular Disease, Ophthalmology +13

Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness).

Eric Pearlman, Jonathan H. Lass, David S. Bardenstein et al. · The Journal of Experimental Medicine · 1995 · 85 citations · Full text

Immunology, Experimental Onchocercal Keratitis, Immune System +18